The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.

The overturning of Roe v. Wade is impacting access to medical abortion, but in what ways is pharma trying to help?

Two US pricing experts dissect the implications of The Inflation Reduction for the pharma industry in this roundtable.

Landmark science has led to an inundation of new transformative therapies, but is the cell and gene market at the point of saturation?

What techniques can pharma companies adopt and adapt from the tech giants dominating the stage of modern-day innovation?

What drives Novartis Oncology’s Reshema Kemps-Polanco to succeed?

Five minutes with Anat Cohen-Dayag, CEO of clinical-stage drug discovery and development company Compugen.

After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future may look more promising.